Richard D. Schulick

56.7k citations
347 papers · 32.7k indexed · 9 hit papers · h-index 86
Topics
Pancreatic and Hepatic Oncology Research (188 papers)Cholangiocarcinoma and Gallbladder Cancer Studies (73 papers)Neuroendocrine Tumor Research Advances (61 papers)
Partner nations
United StatesJapanItaly

In The Last Decade

Richard D. Schulick

330 papers receiving 32.3k citations

Hit Papers

The Clavien-Dindo Classification of Surgical Complications2002202620102018200920112006200220072.5k5.0k7.5k

Peers

Richard D. Schulick
Comparison fields: 5 of 171
  • Oncology 19.7k
  • Surgery 17.3k
  • Pulmonary and Respiratory Medicine 10.6k
  • Epidemiology 6.1k
  • Hepatology 4.6k
Replace Claudio Bassi with:
Claudio Bassi Italy
Jean‐Nicolas Vauthey United States
John L. Cameron United States
Bengt Glimelius Sweden
Timothy M. Pawlik United States
Pierre-Alain Clavien Switzerland
Timothy M. Pawlik United States
Leonard B. Saltz United States
Christopher L. Wolfgang United States
Masatoshi Makuuchi Japan
Richard D. Schulick relative to Claudio Bassi Italy Claudio Bassi's profile →
Citations per field
00.5×3.5×
Claudio Bassi · 1×
Citations per year

Countries citing papers authored by Richard D. Schulick

Since Specialization
Citations

This map shows the geographic impact of Richard D. Schulick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard D. Schulick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard D. Schulick more than expected).

Fields of papers citing papers by Richard D. Schulick

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard D. Schulick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard D. Schulick. The network helps show where Richard D. Schulick may publish in the future.

Co-authorship network of co-authors of Richard D. Schulick

This figure shows the co-authorship network connecting the top 25 collaborators of Richard D. Schulick. A scholar is included among the top collaborators of Richard D. Schulick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard D. Schulick. Richard D. Schulick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 0
3 0
4 0
5 1
6 2
7 13
8 4
9 11
10 22
11 15
12 0
13 3
14 9
15 126
16
DAXX / ATRX , MEN1 , and mTOR Pathway Genes Are Frequently Altered in Pancreatic Neuroendocrine Tumorsbreakdown →
1244
17
Recurrent GNAS Mutations Define an Unexpected Pathway for Pancreatic Cyst Developmentbreakdown →
562
18 69
19 29
20 48

About Richard D. Schulick

Richard D. Schulick is a scholar working on Oncology, Hepatology and Surgery, having authored 347 papers that have together received 32.7k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (188 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (73 papers) and Neuroendocrine Tumor Research Advances (61 papers). The work is most often cited by research in Oncology (19.7k citations), Hepatology (4.6k citations) and Surgery (17.3k citations). Richard D. Schulick has collaborated with scholars based in United States, Japan and Italy. Frequent co-authors include John L. Cameron, Michael A. Choti, Christopher L. Wolfgang, Barish H. Edil, Ralph H. Hruban, Jean‐Nicolas Vauthey, Timothy M. Pawlik, Ksenija Slankamenac, Rolf Graf and René Vonlanthen. Their work appears in journals such as Science, Nature Communications and The Journal of Experimental Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026